Sunday, November 12, 2023

Who's the New Weight-Loss Drug Approved For?

You passed medical training, now see if you can pass our weekly quiz
 
 
MEDPAGE TODAY
 
 
 
 
Weekly News Quiz
Sunday, November 12, 2023
 
 
 
Who's the New Weight-Loss Drug Approved For?
 
You passed medical training, now see if you can pass our weekly quiz
 

The FDA approved tirzepatide (Zepbound) alongside a reduced-calorie diet and increased physical activity for chronic weight management in what patient population? 

    Adults with obesity
    Adults with overweight and a weight-related condition
    Both of the above
 
   
A Property of Everyday Health group
© 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission.
You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: edwardlorilla1986.acciyo123@blogger.com
Manage Email Preferences   |    Unsubscribe   |   Terms of Use   |   Privacy Policy
Technical Questions: feedback@medpagetoday.com
114 Fifth Avenue 15th Floor New York, NY 10011

No comments:

Post a Comment